MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202518019586 A) filed by Cellectar Biosciences, Inc. on March 05, 2025, for Phospholipid Ether Conjugates As Cancer-Targeting Drug Vehicles.
Inventors include Longcor, Jarrod; Pinchuk, Anatoly; Hoover, Randall; and Huang, Zhongping.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Disclosed herein are therapeutic compounds capable of targeting a broad range of tumor cells. The present disclosure is further directed to compositions comprising the therapeutic compounds, methods of manufacturing the therapeutic compounds, and methods of treating cancer comprising administering the therapeutic compounds.
Disclaimer: Curated by HT Syndication.
